Influence of glycosylation on allelic and cell-specific M(r) variation, receptor processing, and ligand binding of the human complement C3b/C4b receptor

Keyphrases

• Ligand Binding 100%
• Human Complement 100%
• Glycosylation 100%
• Tunicamycin 100%
• Complement C3b/C4b Receptor 100%
• R-value 66%
• Granulocytes 66%
• Endoglycosidase 66%
• Non-glycosylated 66%
• Metabolism 33%
• Polypeptide 33%
• Monocytes 33%
• Erythrocytes 33%
• N-linked Oligosaccharide 33%
• O-linked Oligosaccharides 33%
• Polymorphism 33%
• Epstein-Barr Virus 33%
• Structural Variation 33%
• Complex Type 33%
• Membrane Glycoproteins 33%
• Turnover Rate 33%
• Allelic Variation 33%
• Allelic Variants 33%
• Fractionation Patterns 33%
• Surface Membrane 33%
• HL-60 Cells 33%
• Leukemic Cells 33%
• Glycan Receptors 33%
• Glucosamine 33%
• Lymphoblastoid Cell Lines 33%
• Specific Difference 33%
• Specific Variation 33%
• N-glycosylation 33%
• Promyelocytic 33%
• Membrane Insertion 33%
• Lectin Affinity Chromatography 33%
• B-lymphoblastoid Cell Lines 33%

Biochemistry, Genetics and Molecular Biology

• Complement Receptor 1 100%
• Ligand Binding 100%
• Glycosylation 100%
• Tunicamycin 75%
• Oligosaccharide 50%
• Precursor 50%
• Endoglycosidase 50%
• Polymorphonuclear Cell 50%
• Membrane Protein 25%
• Metabolic Pathway 25%
• Lectin 25%
• Epstein Barr Virus 25%
• Fractionation 25%
• Affinity Chromatography 25%
• Glucosamine 25%
• Allelic Variation 25%

Immunology and Microbiology

• Glycosylation 100%
• Complement Receptor 1 100%
• Ligand Binding 100%
• Granulocyte 50%
• Precursor 50%
• Cell Line 25%
• Fractionation 25%
• Lectin 25%
• Glycoprotein 25%
• Affinity Chromatography 25%
• Lymphoblastoid Cell Line 25%
• B-Lymphoblastoid Cell Line 25%
• Epstein Barr Virus 25%
• Erythrocyte 25%